NEVRO CORP. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows in 2024. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2024-05-17: Reporting owner Christoforou Christofer; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2024-05-17: Reporting owner Christoforou Christofer; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2024-05-17: Reporting owner Christoforou Christofer; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2024-05-17: Reporting owner Christoforou Christofer; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-05-17 holding as of filing | Christoforou Christofer Officer (SVP, Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $97.52 exercise price | 2024-05-17 | ||
| 2024-05-17 holding as of filing | Christoforou Christofer Officer (SVP, Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $87.62 exercise price | 2024-05-17 | ||
| 2024-05-17 holding as of filing | Christoforou Christofer Officer (SVP, Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $76.81 exercise price | 2024-05-17 | ||
| 2024-05-17 holding as of filing | Christoforou Christofer Officer (SVP, Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $42.30 exercise price | 2024-05-17 |